Preparation and evaluation of transdermal naproxen niosomes: formulation optimization to preclinical anti-inflammatory assessment on murine model

References

• Abidin, L., et al., 2016. Enhanced transdermal delivery of Luteolin via non-ionic surfactant based vesicle: quality evaluation and anti-arthritic assessment. Drug delivery, 23(3), 1069–1074.
   Web of Science ®Google Scholar
• Ahmed, S., et al., 2016. In vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic. Artificial cells, nanomedicine, and biotechnology, 44(8), 1793–1802.
   PubMed Web of Science ®Google Scholar
• Akhtar, M., et al., 2014. Neuroprotective study of Nigella sativa loaded oral provesicular lipid formulation: in vitro and ex vivo study. Drug delivery, 21(6), 487–494.
   PubMed Web of Science ®Google Scholar
• Barakat, N.S., 2010. Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen. AAPS PharmSciTech, 11(3), 1138–1146.
   PubMed Web of Science ®Google Scholar
• Beetge, E., et al., 2000. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAIDs on their transdermal absorption. International journal of pharmaceutics, 193(2), 261–264.
   PubMed Web of Science ®Google Scholar
• Blazek-Welsh, A.I., and Rhodes, D.G., 2001. Maltodextrin-based proniosomes. AAPS pharmsci, 3(1), 1–8.
   PubMed Web of Science ®Google Scholar
• Bragagni, M., et al., 2015. Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy. International journal of pharmaceutics, 494(1), 258–263.
   PubMed Web of Science ®Google Scholar
• Chopra, S., Patil, G.V., and Motwani, S.K., 2007. Release modulating hydrophilic matrix systems of Losartan potassium: optimization of formulation using statistical experimental design. European journal of pharmaceutics and biopharmaceutics, 66(1), 73–82.
   PubMed Web of Science ®Google Scholar
• Csoka, G., Marton, S., and Zelko, R., 2007. Application of sucrose fatty acid esters in transdermal therapeutic systems. European journal of pharmaceutics and biopharmaceutics, 65, 233–237.
   PubMed Web of Science ®Google Scholar
• Essa, E.A., 2010. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian Journal of Pharmaceutics, 4(4), 227–233.
   Google Scholar
• Fakhria, A., et al., 2019. Formulation of thymoquinone loaded chitosan nano vesicles: in-vitro evaluation and in-vivo anti-hyperlipidemic assessment. Journal of Drug Delivery Science and Technology, 50, 339–346.
   Web of Science ®Google Scholar
• Gannu, R., et al., 2010. Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box Behnken statistical design. AAPS PharmSciTech, 11(2), 976–985.
   PubMed Web of Science ®Google Scholar
• Hal, D., Jeremiasse, E., and Vringer, T., 1996. Encapsulation of lidocaine base and hydrochloride into non-ionic surfactant vesicles (NSVs) and diffusion through human stratum comeum in vitro. European journal of pharmaceutical sciences, 4, 147–157.
   Web of Science ®Google Scholar
• Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by a niosome system. International journal of pharmaceutics, 244(1–2), 73–80.
   PubMed Web of Science ®Google Scholar
• Imam, S.S., et al., 2017. Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal. Materials science and engineering: C, 75, 1198–1205.
   PubMed Web of Science ®Google Scholar
• Imam, S.S., et al., 2015. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug delivery, 22(8), 1059–1070.
   PubMed Web of Science ®Google Scholar
• Jamal, M., et al., 2015. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems. International immunopharmacology, 29(2), 361–369.
   PubMed Web of Science ®Google Scholar
• Jantharaprapap, R., and Stagni, G., 2007. Effects of penetration enhancers on in vitro permeability of Meloxicam Gels. International Journal of Pharmaceutics, 343(1–2), 26–33.
   PubMed Web of Science ®Google Scholar
• Kapoor, M., et al., 2019. Formulation of amlodipine nano lipid carrier: formulation design, physicochemical and transdermal absorption investigation. Journal of drug delivery science and technology, 49, 209–218.
   Web of Science ®Google Scholar
• Kazi, K.M., et al., 2010. Niosome: a future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research, 1(4), 374–380.
   PubMedGoogle Scholar
• Khan, K., et al., 2018. Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment. Biomedicine & pharmacotherapy, 106, 1578–1585.
   PubMed Web of Science ®Google Scholar
• Lee, S.C., et al., 2005. The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. Journal of liposome research, 15(3–4), 157–166.
   PubMed Web of Science ®Google Scholar
• Li, Q., et al., 2014. Proniosome derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. European journal of pharmaceutical sciences, 62, 115–123.
   PubMed Web of Science ®Google Scholar
• Moghassemi, S., and Hadjizadeh, A., 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release, 185, 22–36.
   PubMed Web of Science ®Google Scholar
• Moghassemi, S., et al., 2015. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. Materials science and engineering: C, 46, 333–340.
   PubMed Web of Science ®Google Scholar
• Moghddam, S.R.M., et al., 2016. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor:3-level Box-Behnken design for the management of psoriasis. Materials science and engineering: C, 69, 789–797.
   PubMed Web of Science ®Google Scholar
• Mokhtar, M., et al., 2008. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International journal of pharmaceutics, 361(1–2), 104–111.
   PubMed Web of Science ®Google Scholar
• Ogiso, T., Niinaka, N., and Iwaki, M., 1996. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. Journal of pharmaceutical sciences, 85(1), 57–64.
   PubMed Web of Science ®Google Scholar
• Okur, N.U., Yavaşoglu, A., and Karasulu, H.Y., 2014. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery. Chemical and pharmaceutical bulletin, 62(2), 135–143.
   PubMed Web of Science ®Google Scholar
• Okur, N.U., et al., 2011. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. International journal of pharmaceutics, 416(1), 136–144.
   PubMed Web of Science ®Google Scholar
• Osmałek, T., et al., 2017. Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation. Pharmaceutical development and technology, 22(4), 521–536.
   PubMed Web of Science ®Google Scholar
• Pardakhty, J., Varshosaz, A., and Rouholamini, A., 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics, 328(2), 130–141.
   PubMed Web of Science ®Google Scholar
• Patwardhan, S., Patil, M., and Sockalingam, A., 2017. Development and evaluation of naproxen sodium gel using piper cubeba for enhanced transdermal drug delivery and therapeutic facilitation. Recent patents on drug delivery & formulation, 11(1), 28–35.
   PubMedGoogle Scholar
• Prasad, P.S., et al., 2016. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes. Drug delivery, 23(3), 1047–1056.
   PubMed Web of Science ®Google Scholar
• Puglia, C., et al., 2010. Evaluation of percutaneous absorption of naproxen from different liposomal formulations. Journal of pharmaceutical sciences, 99(6), 2819–2829.
   PubMed Web of Science ®Google Scholar
• Qumbar, M., et al., 2017. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomedicine & Pharmacotherapy, 93, 255–266.
   PubMed Web of Science ®Google Scholar
• Sahoo, R.K., Biswas, N., et al., 2014. Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide–maltodextrin complex. Acta pharmaceutica sinica B, 4(5), 408–416.
   PubMed Web of Science ®Google Scholar
• Sayeed, S., et al., 2017. Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy. Drug development and industrial pharmacy, 43(9), 1413–1420.
   PubMed Web of Science ®Google Scholar
• Szura, D., et al., 2014. The impact of liposomes on transdermal permeation of naproxen–in vitro studies. Acta Poloniae pharmaceutica, 71(1), 145–151.
   PubMed Web of Science ®Google Scholar
• Tari, D., et al., 2017. A simple egg membrane model for understanding diffusion characteristics of nanoparticles and amino acids. Current science, 112(07), 1574–1578.
   Google Scholar
• Winter, C.A., Risley, E., and Nuss, G., 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs . Proceedings of the Society for Experimental Biology and Medicine (New York, N.Y.), 111, 544–547.
   PubMed Web of Science ®Google Scholar